缺血性脑卒中的发病机制及治疗药物的最新进展
摘要
关键词
全文:
PDF参考
[1].Donkor ES, 2018. Stroke in the 21(st) Century: A Snapshot of theBurden, Epidemiology, and Quality of Life. Stroke Res Treat 2018,3238165.[2].Karatepe AG, Gunaydin R, Kaya T, Turkmen G, 2008.Comorbidity in patients after stroke: impact on functional outcome. JRehabil Med 40, 831-835.[3].Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK,He J, 2005. Global burden of hypertension: analysis of worldwide data.Lancet 365, 217-223.[4].Sato M, Tani E, Fujikawa H, Kaibuchi K, 2000. Involvement ofRho-kinase-mediated phosphorylation of myosin light chain inenhancement of cerebral vasospasm. Circ Res 87, 195-200.[5]. Zhang X,Dong H,LiN,et al.Activated brain mast cells contributeto postoperative cognitive dysfunction by evoking microglia activation andneuronal apoptosis[1].Journal of neuroinflammation, 2016,13(1): 1-15.[6].Herpich F, Rincon F. Management of Acute Ischemic Stroke.Crit Care Med. 2020 Nov;48(11):1654-1663. doi: 10.1097/CCM. 0000000000004597. PMID: 32947473; PMCID: PMC7540624.[7].McKay , J.; Mensah, G.A.; Mendis, S.; Greenlund, K.; WorldHealth Organization. The Atlas of Heart Diseaseand Stroke; WHO:Geneva, Switzerland, 2004.[8].孙慧英,李涛.脑卒中及其危险因素分析[J].卒中与神经疾病,2012,19(03):167-170.[9].涂雪松.缺血性脑卒中的流行病学研究[J].中国临床神经科学,2016,24(05):594-599.[10].Mishra, M.; Hedna, V .S. Neuroinflammation after acuteischemic stroke: A volcano hard to contain. Chin.J. Contemp. Neurol.Neurosurg. 2013, 13, 964.[11]. Iadecola, C.; Anrather, J. The immunology of stroke: Frommechanisms to translation. Nat. Med. 2011, 17,796-808.[12].Weiner, H.L.; Selkoe, D.J. Inflammation and therapeuticvaccination in CNS diseases. Nature 2002, 420,879-884.[13].Tuttolomondo, A.; Maida, C.; Pinto, A. Inflammation andInflammatory Cell Recruitment in AcuteCerebrovascular Diseases. Curr.Immunol. Rev. 2015, 11, 24-32.[14].Wei Z, Lyu Y, Yang X, Chen X, Zhong P, Wu D, 2018.Therapeutic Values of Human Urinary Kallidinogenase on Cerebrovascular Diseases. Front Neurol 9, 403.[15].Lee MMY, Sattar N, McMurray JJV, Packard CJ, 2019. Statinsin the Prevention and Treatment of Heart Failure: a Review of theEvidence. Curr Atheroscler Rep 21, 41.[16].Balduini W, De Angelis V, Mazzoni E, Cimino M, 2001.Simvastatin protects against long-lasting behavioral and morphologicalconsequences of neonatal hypoxic/ischemic brain injury. Stroke 32,2185-2191.[17].Jincai W, Tingfang D, Yongheng Z, Zhongmin L, Kaihua Z,Xiaohong L, 2014. Effects of vinpocetine and ozagrel on behavioralrecovery of rats after global brain ischemia. J Clin Neurosci 21, 661²663.[18].Wang H, Zhang K, Zhao L, Tang J, Gao L, Wei Z, 2014.Anti-inflammatory effects of vinpocetine on the functional expression ofnuclear factor-kappa B and tumor necrosis factor-alpha in a rat model ofcerebral ischemia-reperfusion injury. Neurosci Lett 566, 247-251.[19].Yoshida H, Yanai H, Namiki Y, Fukatsu-Sasaki K, Furutani N,Tada N, 2006. Neuroprotective effects of edaravone: a novel free radicalscavenger in cerebrovascular injury. CNS Drug Rev 12, 920.[20].Kitagawa Y, 2006. Edaravone in acute ischemic stroke. InternMed 45, 225-226.[21].Banno M, Mizuno T, Kato H, Zhang G, Kawanokuchi J, Wang J,Kuno R, Jin S, Takeuchi H, Suzumura A, 2005. The radical scavengeredaravone prevents oxidative neurotoxicity induced by peroxynitrite andactivated microglia. Neuropharmacology 48, 283²290.[22]Zhu Z, Fu Y, Tian D, Sun N, Han W, Chang G, Dong Y, Xu X,Liu Q, Huang D, Shi FD, 2015. Combination of the Immune ModulatorFingolimod With Alteplase in Acute Ischemic Stroke: A Pilot Trial.Circulation 132, 1104-1112.[23]Ellery SJ, Goss MG, Brew N, Dickinson H, Hale N, LaRosa DA,Walker DW, Wong FY, 2019. Evaluation of 3K3A-Activated Protein C toTreat Neonatal Hypoxic Ischemic Brain Injury in the Spiny Mouse.Neurotherapeutics 16, 231-243.
DOI: http://dx.doi.org/10.12361/2661-3603-05-18-145511
Refbacks
- 当前没有refback。